Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
20,80 € ↑0,04 (0,19%)
2026-06-05
DEL PRIS
SecurityDE:5EA / Elanco Animal Health Incorporated
InstitutionGabelli Funds Llc
Latest Disclosed Ownership134,250 shares
Latest Disclosed Value $ 3,212,603
Gabelli Funds Llc reports 1.63% increase in ownership of 5EA / Elanco Animal Health Incorporated

On May 14, 2026 - Gabelli Funds Llc filed a 13F-HR form disclosing ownership of 134,250 shares of Elanco Animal Health Incorporated (DE:5EA) valued at $2,738,029 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 132,100 shares of Elanco Animal Health Incorporated. This represents a change in shares of 1.63% during the quarter. The current value of the position is $2,792,400 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 134,250 2,150 1.63 3,213 7.46 0.0217
2026-02-05 2025-12-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 132,100 -23,900 -15.32 2,989 -4.84 0.0202
2025-11-12 2025-09-30 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 156,000 -500 -0.32 3,142 40.60 0.0213
2025-08-13 2025-06-30 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 156,500 -3,000 -1.88 2,235 33.45 0.0159
2025-05-14 2025-03-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 159,500 -2,500 -1.54 1,675 -14.64 0.0128
2025-02-13 2024-12-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 162,000 -2,500 -1.52 1,962 -18.83 0.0147
2024-11-13 2024-09-30 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 164,500 -3,000 -1.79 2,417 -0.04 0.0174
2024-08-13 2024-06-30 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 167,500 0 0.00 2,417 -11.34 0.0184
2024-05-14 2024-03-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 167,500 -500 -0.30 2,727 8.91 0.0201
2024-02-13 2023-12-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 168,000 -10,000 -5.62 2,503 25.15 0.0193
2023-11-08 2023-09-30 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 178,000 -1,500 -0.84 2,001 10.80 0.0162
2023-08-10 2023-06-30 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 179,500 6,500 3.76 1,806 11.01 0.0137
2023-05-12 2023-03-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 173,000 -4,000 -2.26 1,626 -24.79 0.0123
2023-02-13 2022-12-31 13F ELANCO ANIMAL HEALTH EQUITY 28414H103 177,000 -47,000 -20.98 2,163 -22.23 0.0168
2022-11-14 2022-09-30 13F/A-1 ELANCO ANIMAL HEALTH INC COM COM 28414H103 224,000 -5,000 -2.18 2,780 -38.15 0.0229
2022-11-10 2022-09-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 224,000 -5,000 2,780 0.0229
2022-08-12 2022-06-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 229,000 85,000 59.03 4,495 19.64 0.0345
2022-05-18 2022-03-31 13F/A-1 ELANCO ANIMAL HEALTH INC COM COM 28414H103 144,000 19,000 15.20 3,757 5.89 0.0247
2022-05-13 2022-03-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 144,000 19,000 3,757 0.0254
2022-02-11 2021-12-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 125,000 25,950 26.20 3,548 12.31 0.0224
2021-11-12 2021-09-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 99,050 35,050 54.77 3,159 42.30 0.0209
2021-08-13 2021-06-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 64,000 -500 -0.78 2,220 16.84 0.0141
2021-05-14 2021-03-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 64,500 2,200 3.53 1,900 -0.58 0.0127
2021-02-05 2020-12-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 62,300 4,800 8.35 1,911 18.99 0.0136
2020-11-06 2020-09-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 57,500 -100 -0.17 1,606 29.94 0.0125
2020-08-13 2020-06-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 57,600 700 1.23 1,236 -2.98 0.0101
2020-05-14 2020-03-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 56,900 11,400 25.05 1,274 -4.93 0.0114
2020-02-14 2019-12-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 45,500 -500 -1.09 1,340 9.57 0.0087
2019-11-01 2019-09-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 46,000 -650 -1.39 1,223 -22.45 0.0081
2019-08-02 2019-06-30 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 46,650 -9,204 -16.48 1,577 -11.95 0.0101
2019-05-02 2019-03-31 13F ELANCO ANIMAL HEALTH INC COM COM 28414H103 55,854 55,854 1,791 0.0113
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.